Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
About this item
Full title
Author / Creator
Publisher
Cheshire: Springer Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
Cheshire: Springer Healthcare
Subjects
More information
Scope and Contents
Contents
Introduction
Reviews of randomized clinical trials (RCTs) in dementia with Lewy bodies (DLB) are essential for informing ongoing research efforts of symptomatic therapies and potentially disease-modifying therapies (DMTs).
Methods
We performed a systematic review of all clinical trials conducted until September 27, 2022, by examining 3 int...
Alternative Titles
Full title
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1098fd9019dd4ba8a04039d27687ce28
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1098fd9019dd4ba8a04039d27687ce28
Other Identifiers
ISSN
2193-8253
E-ISSN
2193-6536
DOI
10.1007/s40120-023-00467-8
